Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy
- 23 March 2005
- journal article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 34 (4) , 295-301
- https://doi.org/10.1016/j.jcv.2005.02.004
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Complementation in Cells Cotransfected with a Mixture of Wild-Type and Mutant Human Immunodeficiency Virus (HIV) Influences the Replication Capacities and Phenotypes of Mutant Variants in a Single-Cycle HIV Resistance AssayJournal of Clinical Microbiology, 2004
- Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV‐infected patients experiencing prolonged virologic failureJournal of Medical Virology, 2004
- Resistance to enfuvirtide, the first HIV fusion inhibitorJournal of Antimicrobial Chemotherapy, 2004
- Relative Replicative Fitness of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide (T-20)Journal of Virology, 2004
- HIV Drug ResistanceNew England Journal of Medicine, 2004
- Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytesNature Reviews Drug Discovery, 2004
- Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and AustraliaNew England Journal of Medicine, 2003
- Baseline Susceptibility of Primary Human Immunodeficiency Virus Type 1 to Entry InhibitorsJournal of Virology, 2003
- Rate of Virological Treatment Failure and Frequencies of Drug Resistance Genotypes among Human Immunodeficiency Virus-Positive Subjects on Antiretroviral Therapy in SpainJournal of Clinical Microbiology, 2002
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994